CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
Season 1 – Episode 43 – Understanding the Regulation of Cell Therapy Products Discusses the regulation of cell therapy products and the importance of training…
Introduction Software systems increasingly shape how people access healthcare, education, financial services, employment opportunities, and civic participation. As software’s influence expands, ethical failures, such as…
Overview NIH continues to clarify its clinical trial definition and identification to support transparency and consistency in human research. The 2014 policy revision (NOT-OD-15-015) and…
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
Season 3 – Episode 15 – Rethinking Child Assent Practices In this episode, we discuss rethinking child assent beyond procedural compliance. Notes To…
Season 4 – Episode 3 – Gen Z Expectations for College and the Future of Higher Education In this episode, we explore what Gen Z…
What Researchers, Sponsors, and Institutions Should Know In March 2026, the National Institutes of Health (NIH) released two draft resources to improve the design, conduct,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
Overview Quantitative research is often assumed to be low risk, especially when it involves surveys, secondary data analysis, or online data collection. For Institutional Review…
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
“CITI Program Funding Finds” is our monthly blog series which highlights opportunities relevant to research grants, funding, programs open to new applicants, and more. Follow…
